Ralf Kuriyel - Aug 2, 2024 Form 4 Insider Report for REPLIGEN CORP (RGEN)

Role
Senior VP, R&D
Signature
/s/ Kenneth O'Brien (Attorney in Fact)
Stock symbol
RGEN
Transactions as of
Aug 2, 2024
Transactions value $
-$1,123,949
Form type
4
Date filed
8/5/2024, 09:56 PM
Previous filing
Aug 1, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RGEN Common Stock Sale -$1.11M -6.97K -36.2% $159.36 12.3K Aug 2, 2024 Direct
transaction RGEN Common Stock Options Exercise $15.1K +175 +1.42% $86.10 12.5K Aug 2, 2024 Direct
transaction RGEN Common Stock Sale -$27.8K -175 -1.4% $158.85 12.3K Aug 2, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RGEN Stock Option (Right to Buy) Options Exercise $0 +175 $0.00* 0 Aug 2, 2024 Common Stock 175 $86.10 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option is fully vested and exercisable. Exhibit 24.1: Power of Attorney